Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Charles Russell Speechlys has advised longstanding client Emergex Vaccines Holding Limited on their recent $11m equity fundraising to advance its vaccine development programme for infectious diseases.
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines against health threats such as COVID-19, Dengue Fever, Zika, Ebola, pandemic flu and serious intra-cellular bacterial infections.
This was a follow-on round with new and existing investors after Emergex raised over $11m earlier this year in a Series A round led by a Singaporean venture capital investor, which we also advised on. Alongside this transaction, we continue to advise on Emergex’s UK and international research and development collaborations and ventures (including a Brazilian collaboration and the launch of its US subsidiary by acquisition of a US research lab).
Storme Moore-Thornicroft, co-founder and COO of Emergex, commented: “This funding round demonstrates our investors’ continuing confidence in Emergex’s unique technology in creating safe, effective vaccines that can be rapidly developed and deployed against a range of infectious diseases. Many thanks to Will and the Charles Russell Speechlys team for their instrumental advice, both from a transactional and advisory perspective.”
Will Nash commented: “We are delighted to have supported Emergex through their recent fundraising rounds which will facilitate their exciting and innovative work on deploying new technologies to develop vaccines against some of the world’s most immediate heath threats.”
The Charles Russell Speechlys team was led by Corporate Partner Will Nash and included Senior Associate Caroline Young and Associate Svetlana Kisyova.
Our thinking
Charlotte Posnansky
VV v VV - Just 5 months of marriage and the most expensive train ticket ever?
Mark Howard
Charles Russell Speechlys advises Content+Cloud on the acquisition of award-winning service provider Azzure IT
Content+Cloud continues its growth journey, this is our 7th successful transaction for them.
Dominic Lawrance
Dominic Lawrance talks to Spear's Magazine about UK cryptocurrency tax
What HNWs should know about UK cryptocurrency tax
Sarah Keens
Being Green - The Struggle for Power
Everything you need to know about Green Leases
Rose Carey
Is the UK open for business? A discussion with the Home Office
We hosted an immigration webinar with the policymakers from the Home Office.
Louise Ward
Louise Ward writes for EG on what UK investors can gain from an overseas life sciences partner
What UK investors can gain from an overseas life sciences partner
Sonia Kenawy
Sonia Kenawy writes for New Law Journal on cryptocurrency and security for costs
Sonia Kenawy writes for New Law Journal on cryptocurrency and security for costs
David Haines
New Arbitration Scheme for Commercial Arrears goes live
Everything you need to know about the new Arbitration Scheme for Commercial Arrears
Charlotte Healy
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Pei Li Kew
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Charlotte Duly
Charlotte Duly writes for CITMA Review on the China Tang trade mark infringement case
Charlotte Duly writes for CITMA Review on the China Tang trade mark infringement case
Mark Howard
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Charles Russell Speechlys advises Acora on its acquisition of Secrutiny
Oliver Park
Building Safety Act 2022
Everything you need to know about the Building Safety Act 2022
Jonathan McDonald
Jonathan McDonald provides comment for City AM on the Data Reform Bill announced in the Queen's Speech
Jonathan McDonald provides comment for City AM on the Data Reform Bill announced in the Queen's Speech
Claire Fallows
CoStar quotes Claire Fallows on the new infrastructure levy announced in the Queen's Speech
CoStar quotes Claire Fallows on the new infrastructure levy announced in the Queen's Speech
Charlotte Posnansky
Depp v Heard - will transparency in the English family court increase public confidence or feed the insatiably prurient public appetite?
Nick White
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million
Charles Russell Speechlys advises Symphony Holdings Limited on the sale of its PONY trade mark portfolio for USD $28 million.
Hope Wilson
Hope Wilson writes for the EG Legal Q&A on qualifying criteria
Hope Wilson writes for the EG Legal Q&A on qualifying criteria
Simon Ridpath
Simon Ridpath featured in the Lawyer’s Hot 100 list
Simon Ridpath features in The Lawyer’s Hot 100 list
Mark Howard
Charles Russell Speechlys advises Europa Oil & Gas (Holdings) plc on its £7m equity fundraising
Europa Oil and Gas is a renewable energy, oil and gas development and production company.